The Effect of Anterior Corneal Incisions on Intraoperative Floppy Iris Syndrome (IFIS) Incidence and Severity in Tamsulosin Treated Cataract Patients
1 other identifier
interventional
40
1 country
1
Brief Summary
Intraoperative Floppy Iris Syndrome (IFIS) may occur during cataract surgeries in patients treated with alpha 1 blockers. IFIS related to alpha 1 blocker Tamsulosin (used for prostate hypertrophy) was reported in 50-90% of patients. IFIS during surgery make the surgery more difficult and raise complication rate. Using anterior corneal incisions was reported briefly in literature as a prophylactic means but was not studied prospectively. we believe (according to our clinical experience) that these anterior incisions do help to reduce the incidence and severity of IFIS signs and complications rate during surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2010
CompletedFirst Posted
Study publicly available on registry
February 18, 2010
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedJuly 1, 2013
March 1, 2013
3.4 years
February 17, 2010
June 27, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the number of IFIS cases observed during operation.
during the operations
Secondary Outcomes (1)
assessing the clinical grade of observed IFIS cases
during the operations
Study Arms (1)
anterior corneal incision
EXPERIMENTALInterventions
3 corneal paracentesis incisions will be located 1 mm anterior to the limbus.
Eligibility Criteria
You may qualify if:
- cataract candidates treated (in the present or in the past) with tamsulosin
- aged 55 or more
- candidates for topical anesthesia
- no allergy to anticholinergic or adrenergic drugs
- able to understand and sign an informed consent
You may not qualify if:
- history of uveitis
- iris neovascularization
- s/p iris surgery
- traumatic/uveitis induced cataract
- dialysis / abscence of zonules
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Meir Medical Center
Kfar Saba, Israel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2010
First Posted
February 18, 2010
Study Start
July 1, 2010
Primary Completion
December 1, 2013
Study Completion
March 1, 2014
Last Updated
July 1, 2013
Record last verified: 2013-03